➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Baxter
Harvard Business School
Colorcon
Boehringer Ingelheim

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Tetracycline hydrochloride - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for tetracycline hydrochloride and what is the scope of patent protection?

Tetracycline hydrochloride is the generic ingredient in fourteen branded drugs marketed by Avet, Bristol, Warner Chilcott, Pharmacia And Upjohn, Solvay, Wyeth Ayerst, Apothecon, Angus, Abbott, Amneal Pharms Ny, Ani Pharms Inc, Breckenridge, Chartwell Tetra, Elkins Sinn, Ferrante, Heather, Hikma Pharms, Impax Labs, Ivax Sub Teva Pharms, Mast Mm, Mylan, Purepac Pharm, Pvt Form, Roxane, Strides Pharma, Sun Pharm Industries, Superpharm, Valeant Pharm Intl, Watson Labs, Pfipharmecs, Schiff And Co, Shire, Lederle, Pfizer, Storz, Par Pharm, Alpharma Us Pharms, and Proter, and is included in fifty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are ninety-nine drug master file entries for tetracycline hydrochloride. Ten suppliers are listed for this compound.

Recent Clinical Trials for tetracycline hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
xjpfWN/A
Kenya Medical Research InstitutePhase 4
Kenya National AIDS & STI Control ProgrammePhase 4

See all tetracycline hydrochloride clinical trials

Pharmacology for tetracycline hydrochloride

US Patents and Regulatory Information for tetracycline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avet ACHROMYCIN V tetracycline hydrochloride CAPSULE;ORAL 050278-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Heather TETRACYCLINE HYDROCHLORIDE tetracycline hydrochloride CAPSULE;ORAL 061148-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hikma Pharms TETRACYCLINE HYDROCHLORIDE tetracycline hydrochloride CAPSULE;ORAL 060768-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Baxter
Harvard Business School
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.